Delivery Order SPE2DB24D9223-SPE2DB25FKELA
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $30,127.56 by the Defense Logistics Agency on August 20, 2025. The contract calls for the delivery of Exparel 266 mg/20 ml vials, a liposomal bupivacaine formulation used for post-operative pain management. The award carries no set-aside designation, and performance is scheduled for completion by September 11, 2025, with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $25,106.30 firm fixed-price delivery order by the Defense Logistics Agency on August 14, 2025, for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 mL vials. The contract carries an ultimate completion date of September 5, 2025, and involves no set-aside designation. This delivery order represents a continuation of DMS Pharmaceutical Group's substantial role...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $7,531.89 by the Defense Logistics Agency on August 27, 2025. The contract calls for the delivery of EXPAREL 266 mg/20 ml vials, a local anesthetic medication used in surgical and post-operative pain management. The delivery order is set to be completed by September 18, 2025, with performance taking place at the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $12,553.15 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain division on July 24, 2025. The delivery order calls for the supply of EXPAREL 1.3% in 20-milliliter quantities (10 units), a liposomal bupivacaine formulation used for surgical site infiltration and interscalene brachial plexus nerve block. The contract carries no...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $30,127.56 by the Defense Logistics Agency (DLA) on August 18, 2025. The contract calls for the delivery of EXPAREL (liposomal bupivacaine) 266 mg/20 ml vials, a long-acting local anesthetic commonly used in surgical and post-operative pain management. This firm fixed-price delivery order, with an ultimate completion date of September 9,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency on July 24, 2025, for the supply of EXPAREL 266 mg/20 mL vials. This firm fixed-price delivery order, valued at $50,212.60, is set to be completed by August 14, 2025, with performance taking place at the company's Park Ridge location. The award carries no set-aside designation, reflecting the contractor's competitive...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency for EXPAREL 266 mg/20 mL vials valued at $2,510.63. The contract is classified as firm fixed-price with an ultimate completion date of September 10, 2025. This delivery order was issued without a set-aside designation, reflecting DMS Pharmaceutical Group's competitive standing in the federal procurement market. The place...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $37,659.45 for the supply of EXPAREL 266 mg/20 mL vials. The award, made on August 25, 2025, with an ultimate completion date of September 16, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 19, 2025, by the Defense Logistics Agency (DLA) for Exparel 133 mg/10 mL vials. The contract, valued at $6,028.88, represents a firm fixed-price delivery order with an ultimate completion date of September 10, 2025. This award was executed without a set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $10,042.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on July 21, 2025. The delivery order is for EXPAREL 266 mg/20 mL vials, a liposomal bupivacaine formulation used for local anesthesia and post-operative pain management. The contract carries no set-aside designation, and DMS Pharmaceutical Group is competing as a small business...
- SPE2DB24D9223Indefinite Delivery Contract
- SPE2DB24D9223-SPE2DB25FKELADelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,655.32 by the Defense Logistics Agency on August 28, 2025. The contract covers the delivery of Exparel 133 mg/10 ml vials, a liposomal bupivacaine product used for local anesthesia and postoperative pain management. Performance of this delivery order is scheduled for completion by September 19, 2025, with the place of performance located in Park Ridge, Illinois. No set-aside designation was used in this award. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's SPE2DB program, a $499.99 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a significant supplier within the federal pharmaceutical supply chain, consistently securing contracts for specialty medications, biologics, and medical consumables to military and federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 8/28/25 |